What is BLSM's current stock price?

BLSM (BlossomHill Therapeutics, Inc.) is currently trading at $18.59 with a market cap of $540.6M.

What sector is BlossomHill Therapeutics, Inc. in?

BlossomHill Therapeutics, Inc. (BLSM) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

BLSM BlossomHill Therapeutics, Inc.

NASDAQHealthcare

$18.59-0.27%ClosedMarket Cap: $540.6M

As of 2026-10-01

Why BLSM matters now

BlossomHill Therapeutics, Inc. (BLSM) is a US stock in Healthcare. The latest InvestLog snapshot shows $18.59 with -0.27% on the session and $540.6M in market capitalization.

The latest indexable market news headline is "BlossomHill Therapeutics Presents Preclinical Data on Novel Pan-KRAS Inhibitor, BH-501284, at the AACR Conference on Pancreatic Cancer" from GlobeNewsWire.

Latest News

BlossomHill Therapeutics Presents Preclinical Data on Novel Pan-KRAS Inhibitor, BH-501284, at the AACR Conference on Pancreatic CancerGlobeNewsWire · 2026-09-28

BlossomHill Therapeutics Reports Second Quarter 2026 Financial ResultsGlobeNewsWire · 2026-09-18

BlossomHill Therapeutics Presents Updated Data from Ongoing Phase 1/2 SOLARA Trial Demonstrating Encouraging Anti-Tumor Activity of OMNI-EGFR™ Inhibitor BH-30643 in EGFR C797S-Positive NSCLC at IASLC 2026 World Conference on Lung CancerGlobeNewsWire · 2026-09-15

BlossomHill Therapeutics, Inc.’s Quiet Period Set To Expire on September 16th (NASDAQ:BLSM)Defense World · 2026-09-09

BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment ConferenceGlobeNewsWire · 2026-09-03

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

NASDAQ

Beta

0.00

Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.